Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL1700004	重组全人抗PD-L1单克隆抗体注射液	Recombinant anti-PD-L1 human monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2017-05-17	兆科（广州）肿瘤药物有限公司	Zhaoke (Guangzhou) Oncology Pharmaceutical Limited	Certificate Issued	2018-01-17	view
CXSL2000354	重组全人抗PD-L1单克隆抗体注射液	Recombinant anti-PD-L1 human monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2020-12-16	兆科（广州）肿瘤药物有限公司	Zhaoke (Guangzhou) Oncology Pharmaceutical Limited	In Review	2020-12-14	view
CXSL2000130	重组全人抗PD-L1单克隆抗体注射液	Recombinant anti-PD-L1 human monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2020-07-15	兆科（广州）肿瘤药物有限公司	Zhaoke (Guangzhou) Oncology Pharmaceutical Limited	In Review	2020-07-13	view